Sandoval Elisabeth
Known title: DirectorCIK: 0001632295
Associated companies
Transaction History
| PRCT | ▲ Buy | Grant | 3,315 | $0 | 6/9/2026 | View on chart |
| PRCT | ▲ Buy | Grant | 1,538 | $0 | 6/10/2025 | View on chart |
| PRCT | ▲ Buy | Grant | 1,376 | $0 | 6/4/2024 | View on chart |
| PRCT | ▲ Buy | Grant | 2,711 | $0 | 6/15/2023 | View on chart |
| PRCT | ▲ Buy | Grant | 2,001 | $75K | 6/7/2022 | View on chart |
| PRCT | ▲ Buy | Grant | 4,935 | $200K | 10/21/2021 | View on chart |
AI Market Commentary
AI-generatedAll commentary →Synthesized from recent news and fundamentals/technical data -- not human analyst commentary or trader sentiment.
October 17, 2026
PROCEPT BioRobotics Sets Q3 2026 Earnings Date for Nov 4
PROCEPT BioRobotics has announced it will release its third-quarter 2026 financial results on November 4, 2026. This scheduled update provides investors with a specific date to review the company's recent performance. The announcement serves as a standard corporate disclosure ahead of the earnings release.
PROCEPT BioRobotics Sets Q3 2026 Earnings Date for Nov 4. PROCEPT BioRobotics has announced it will release its third-quarter 2026 financial results on November 4, 2026. This scheduled update provides investors with a specific date to review the company's recent performance. The announcement serves as a standard corporate disclosure ahead of the earnings release.